In utero exposure to antiretroviral drugs and pregnancy outcomes: Analysis of the French ANRS pharmacovigilance database-Reference-Cited by-同舟云学术

In utero exposure to antiretroviral drugs and pregnancy outcomes: Analysis of the French ANRS pharmacovigilance database

Published:2021-10-13 Issue: Volume: Page:
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Saint‐Lary Laura¹^ORCID,Diallo Alpha²,Monteynard Laure‐Amélie³,Paul Christelle²,Marchand Lucie⁴,Tubiana Roland⁵,Warszawski Josiane⁶,Mandelbrot Laurent⁷,Rekacewicz Claire³,Petrov‐Sanchez Ventzislava⁴,Faye Albert⁸,Sibiude Jeanne⁹,Dabis François²¹⁰,Sommet Agnès¹¹¹,Leroy Valériane¹

Affiliation:

1. CERPOP, Inserm, Université de Toulouse, Université Paul Sabatier III Toulouse France

2. Clinical Trial Safety and Public Health ANRS Paris Île‐de‐France France

3. International Research and Collaboration Unit ANRS Paris Île‐de‐France France

4. Clinical and Therapeutic Research on HIV and Hepatitis Unit ANRS Paris Île‐de‐France France

5. University Hospital Pitié Salpêtrière Infectious and Tropical Diseases Service, Sorbonne Université, Inserm UMR‐1136 Pierre Louis Institute of Epidemiology and Public Health Paris Île‐de‐France France

6. Hospital Louis‐Mourier, Obstetrics‐Gynecology Department, Colombes CESP Inserm U1018 Université Paris Diderot Risks in Pregnancy University Department Colombes Île‐de‐France France

7. Hospital Louis‐Mourier, Service de Gynécologie‐Obstétrique, Institut national de la santé et de la recherche médicale Iame‐U1137 Université Paris‐Diderot Colombes Île‐de‐France France

8. Robert‐Debré Mother‐Child University Hospital Division of Paediatric Medicine Université Paris 7 Denis Diderot, Sorbonne Paris Cité, Inserm U1123 Paris Île‐de‐France France

9. Maternité Port‐Royal, Département Hospitalier Universitaire Risques et Grossesse, Inserm U1018 Paris Île‐de‐France France

10. Inserm U1219, University of Bordeaux, ISPED, Bordeaux Population Health Research Center Bordeaux France

11. Service de pharmacologie clinique, CHU de Toulouse, Faculté de Médecine Université Toulouse 3 Toulouse Midi‐Pyrénées France

Funder

Agence Nationale de Recherches sur le Sida et les Hépatites Virales

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15075

Reference69 articles.

1. UNAIDS.2020 Global AIDS Update—Seizing the moment—Tackling entrenched inequalities to end epidemics.https://www.unaids.org/en/resources/documents/2020/global-aids-report. Published July 6 2020. Accessed December 14 2020.

2. WHO.Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection.http://www.who.int/hiv/pub/arv/arv-2016/en/. Published June2016. Accessed December 14 2020.

3. Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis

4. WHO.Lignes directrices unifiées relatives à l'utilisation de médicaments antirétroviraux pour le traitement et la prévention de l'infection à VIH.http://www.who.int/hiv/pub/arv/policy-brief-arv-2015/fr/. Published November 2015. Accessed March 23 2018.

5. Declines in Low Birth Weight and Preterm Birth Among Infants Who Were Born to HIV-Infected Women During an Era of Increased Use of Maternal Antiretroviral Drugs: Pediatric Spectrum of HIV Disease, 1989–2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrase inhibitor drugs during pregnancy and congenital anomalies: A case/non‐case study from the global pharmacovigilance database VigiBase®;Pharmacology Research & Perspectives;2024-07-31

2. Antiretroviral Therapy in Pregnancy: A 2023 Review of the Literature;Current HIV/AIDS Reports;2024-01-26

3. Paxlovid (Nirmatrelvir and Ritonavir) Use in Pregnant and Lactating Woman: Current Evidence and Practice Guidelines—A Scoping Review;Vaccines;2023-01-01

4. Current status of dolutegravir delivery systems for the treatment of HIV-1 infection;Journal of Drug Delivery Science and Technology;2022-10

5. Infections pendant la grossesse : progrès thérapeutiques;Bulletin de l'Académie Nationale de Médecine;2022-02